AstraZeneca has announced a sweeping $50 billion investment across the United States through 2030, marking the company’s largest commitment to U.S. pharmaceutical operations to date. The move signals ...

Though they billed it as a “soft opening,” the renovated, 139,000-square-foot Mount Vernon Recreation Center drew many admiring oohs and ahs on June 9 when local officials and others cut a red ...

AstraZeneca's strategic $50B investment promises to revolutionize U.S. medicine production with advanced manufacturing and ...

The company plans to invest billions in a new drug manufacturing hub in Virginia, dedicated to chronic disease treatments, ...

AstraZeneca (Cambridge, U.K.) announced $50 billion of investment in the United States by 2030, building on America’s global leadership in medicines ...

AstraZeneca (AZ) has become the latest major drugmaker to announce a significant investment in the US, committing $50bn into ...

AstraZeneca has announced $50bn investment plans in the US by 2030 for drug manufacturing, and research and development (R&D) ...

AstraZeneca to invest $50 billion in America for medicines manufacturing and R&D: Cambridge, UK Wednesday, July 23, 2025, 09:00 Hrs [IST] AstraZeneca announces $50 billion of inve ...

AstraZeneca has increased its investment in U.S. operations more than 14-fold, committing $50 billion to a range of ...

AstraZeneca plans to construct a multi-billion dollar manufacturing center focused on chronic diseases in Virginia within the next five years.

AstraZeneca plans a $50 billion investment in U.S. facilities by 2030, including a Virginia plant focused on weight loss and ...

As President Donald Trump’s tariff policies loom, global pharmaceutical giant AstraZeneca will invest $50 billion to boost ...